Clinical diagnostic criteria for dementia associated with Parkinson’s disease

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240

The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia

Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383

The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737

A systematic review of prevalence studies of dementia in Parkinson's disease

Aarsland, D., ZACCAI, J. H., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,714

Prevalence and Characteristics of Dementia in Parkinson Disease

Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403

Rivastigmine for Dementia Associated with Parkinson's Disease

Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., Deyn, P. P. D., Durif, F., Kulisevsky, J., van Laar, T., Lees, A. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,219

Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years

Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050

Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors

Fénelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,035

Clinico-Pathological Correlations of the Most Common Neurodegenerative Dementias

Taipa, R. J. F., Pinho, J., & Pires, M. M. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00068 · Cited by 54

Rapid Eye Movement Sleep Behavior Disorder Symptoms Correlate with Domains of Cognitive Impairment in Parkinson's Disease

Zhang, J., Chen, J., Yang, Z.-J., Zhang, H., Fu, Y., Shen, Y., He, P.-C., Mao, C., & Liu, C. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.176077 · Cited by 52

Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study

Amboni, M., Iuppariello, L., Iavarone, A., Fasano, A. A., Palladino, R., Rucco, R., Picillo, M., Lista, I., Varriale, P., Vitale, C., et al. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8973-x · Cited by 52

Reduced Regional NREM Sleep Slow-Wave Activity Is Associated With Cognitive Impairment in Parkinson Disease

Schreiner, S. J., Imbach, L., Valko, P. O., Maric, A., Maqkaj, R., Werth, E., Baumann, C. R., & Baumann‐Vogel, H. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.618101 · Cited by 56

Functional Connectomics and Disease Progression in Drug‐Naïve Parkinson's Disease Patients

Micco, R. D., Agosta, F., Basaia, S., Siciliano, M., Cividini, C., Tedeschi, G., Filippi, M., & Tessitore, A. (2021) · Movement Disorders · doi:10.1002/mds.28541 · Cited by 53

Relative survival in patients with dementia with Lewy bodies and Parkinson’s disease dementia

Larsson, V., Torisson, G., & Londos, E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202044 · Cited by 57

Transcranial Direct Current Stimulation (tDCS) as a Useful Rehabilitation Strategy to Improve Cognition in Patients With Alzheimer's Disease and Parkinson's Disease: An Updated Systematic Review of Randomized Controlled Trials

Cammisuli, D. M., Cignoni, F., Ceravolo, R., Bonuccelli, U., & Castelnuovo, G. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.798191 · Cited by 55

Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease

Bartl, M., Dakna, M., Schade, S., Otte, B., Wicke, T., Lang, E., Starke, M., Ebentheuer, J., Weber, S., Toischer, K., et al. (2022) · Movement Disorders · doi:10.1002/mds.29257 · Cited by 53

Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology

Kac, P. R., González‐Ortiz, F., Emeršič, A., Dulewicz, M., Koutarapu, S., Turton, M., An, Y., Smirnov, D. S., Kulczyńska‐Przybik, A., Varma, V. R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46876-7 · Cited by 56

Risk of Dementia in Parkinson's Disease: A Systematic Review and Meta‐Analysis

Gibson, L. L., Weintraub, D. A., Lemmen, R., Perera, G., Chaudhuri, К. R., Svenningsson, P., & Aarsland, D. (2024) · Movement Disorders · doi:10.1002/mds.29918 · Cited by 55

Event-related mu-rhythm desynchronization during movement observation is impaired in Parkinson’s disease

Heida, T., Poppe, N. R., de Vos, C. C., van Putten, M. J. A. M., & van Vugt, J. P. P. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.01.016 · Cited by 51

Insulin‐like growth factor‐1 predicts cognitive functions at 2‐year follow‐up in early, drug‐naïve Parkinson's disease

Pellecchia, M. T., Santangelo, G., Picillo, M., Pivonello, R., Longo, K., Pivonello, C., Vitale, C., Amboni, M., Rosa, A. D., Moccia, M., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12137 · Cited by 51

Does a volume reduction of the parietal lobe contribute to freezing of gait in Parkinson's disease?

Rubino, A., Assogna, F., Piras, F., Battista, M. E. D., Imperiale, F., Chiapponi, C., Spalletta, G., & Meco, G. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.07.002 · Cited by 51

Apathy in Parkinson's Disease: More Than Just Executive Dysfunction

Martínez‐Horta, S., Pagonabarraga, J., de Bobadilla, R. F., García‐Sánchez, C., & Kulisevsky, J. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617713000131 · Cited by 53

Contribution of four lifelong factors of cognitive reserve on late cognition in normal aging and Parkinson’s disease

Rouillard, M., Audiffren, M. F., Albinet, C. T., Bahri, M. A., Garraux, G., & Collette, F. (2016) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2016.1207755 · Cited by 51

Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease

Baba, T., Hosokai, Y., Nishio, Y., Kikuchi, A., Hirayama, K., Suzuki, K., Hasegawa, T., Aoki, M., Takeda, A., & Mori, E. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.11.068 · Cited by 51

The relationship between Impulse Control Disorders and cognitive dysfunctions in Parkinson’s Disease: A meta-analysis

Santangelo, G., Raimo, S., & Barone, P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.018 · Cited by 56

Longitudinal diffusion tensor imaging changes in early Parkinson’s disease: ICICLE-PD study

Minett, T., Su, L., Mak, E., Williams, G. B., Firbank, M., Lawson, R. A., Yarnall, A. J., Duncan, G. W., Owen, A. M., Khoo, T. K., et al. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8873-0 · Cited by 51

Origins Matter: Culture Impacts Cognitive Testing in Parkinson’s Disease

Statucka, M., & Cohn, M. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00269 · Cited by 52

Results of prednisolone given to improve the outcome of in vitro fertilization-embryo transfer in women with antinuclear antibodies.

Taniguchi, F. (2005) · PubMed · Cited by 51

Effects of statins on dopamine loss and prognosis in Parkinson’s disease

Jeong, S. H., Lee, H. S., Chung, S. J., Yoo, H. S., Jung, J. H., Baik, K., Lee, Y. H., Sohn, Y. H., & Lee, P. H. (2021) · Brain · doi:10.1093/brain/awab292 · Cited by 50

Theta Burst Magnetic Stimulation Improves Parkinson’s-Related Cognitive Impairment: A Randomised Controlled Study

He, W., Wang, J., & Tsai, P. (2021) · Neurorehabilitation and neural repair · doi:10.1177/1545968321104131 · Cited by 50

Noradrenergic deficits contribute to apathy in Parkinson’s disease through the precision of expected outcomes

Hezemans, F. H., Wolpe, N., O’Callaghan, C., Ye, R., Rua, C., Jones, P. S., Murley, A. G., Holland, N., Regenthal, R., Tsvetanov, K. A., et al. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010079 · Cited by 51

Cerebro-cerebellar motor networks in clinical subtypes of Parkinson’s disease

Basaia, S., Agosta, F., Francia, A., Cividini, C., Balestrino, R., Stojković, T., Stanković, I., Marković, V., Sarasso, E., Gardoni, A., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00377-w · Cited by 50

Optimal MMSE and MoCA cutoffs for cognitive diagnoses in Parkinson's disease: A data-driven decision tree model

Fiorenzato, E., Cauzzo, S., Weis, L., Garon, M., Pistonesi, F., Cianci, V., Nasi, M. L., Vianello, F., Zecchinelli, A., Pezzoli, G., et al. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123283 · Cited by 50

Depression in mild dementia: associations with diagnosis, APOE genotype and clinical features

Fritze, F., Ehrt, U., Sønnesyn, H., Kurz, M. W., Hortobágyi, T., Nore, S. P., Ballard, C. G., & Aarsland, D. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2643 · Cited by 50

Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan

Yu, R., Wu, R., Tai, C., Lin, C., Cheng, T.-W., & Hua, M. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.06.002 · Cited by 50

Nonlinear decline of mini‐mental state examination in Parkinson's disease

Aarsland, D., Terrera, G. M., & Matthews, F. E. (2010) · Movement Disorders · doi:10.1002/mds.23416 · Cited by 50

Striatal volume is related to phonemic verbal fluency but not to semantic or alternating verbal fluency in early Parkinson’s disease

Ellfolk, U., Joutsa, J., Rinne, J. O., Parkkola, R. K., Jokinen, P., & Karrasch, M. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1073-2 · Cited by 50

Grooved Pegboard Predicates More of Cognitive Than Motor Involvement in Parkinson’s Disease

Bezdíček, O., Nikolai, T., Hoskovcová, M., Štochl, J., Brožová, H., Dušek, P., Zárubová, K., Jech, R., & Růžička, E. (2014) · Assessment · doi:10.1177/1073191114524271 · Cited by 50

Can we clinically diagnose dementia with Lewy bodies yet?

Huang, Y. M., & Halliday, G. M. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-4 · Cited by 49

Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?

Merola, A., Rizzi, L., Zibetti, M., Artusi, C. A., Montanaro, E., Angrisano, S., Lanotte, M., Rizzone, M. G., & Lopiano, L. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305271 · Cited by 50

Loss of independence in early Parkinson disease

Bjørnestad, A. L., Tysnes, O., Larsen, J. P., & Alves, G. W. (2016) · Neurology · doi:10.1212/wnl.0000000000003213 · Cited by 50

Clinical milestones in Parkinson's disease: A 7-year population-based incident cohort study

Bjørnestad, A. L., Pedersen, K. F., Tysnes, O., & Alves, G. W. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.05.025 · Cited by 50

Tau/α‐synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study

Delgado‐Alvarado, M., Gago, B., Gorostidi, A., Jiménez‐Urbieta, H., Dacosta‐Aguayo, R., Navalpotro‐Gómez, I., Ruiz‐Martínez, J., Bergareche, A., Martí-Massó, J. F., Martínez‐Lage, P., et al. (2017) · Movement Disorders · doi:10.1002/mds.27001 · Cited by 53

Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)

Jones, A. J., Kuijer, R. G., Livingston, L., Myall, D. J., Horne, K., MacAskill, M. R., Pitcher, T. L., Barrett, P. T., Anderson, T., & Dalrymple‐Alford, J. C. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0085-5 · Cited by 50

Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia

Li, D. T. H., Hui, E. S. K., Chan, Q., Yao, N., Chua, S. E., McAlonan, G. M., Pang, S. Y.-Y., Ho, S. L., & Mak, H. K. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.07.028 · Cited by 50

Visualizing hydrogen peroxide in Parkinson’s disease models via a ratiometric NIR fluorogenic probe

Liu, Y., Bai, L., Li, Y., Ni, Y., Xin, C., Zhang, C., Liu, J., Liu, Z., Li, L., & Huang, W. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.09.107 · Cited by 50

Entorhinal Cortex Atrophy in Early, Drug-naive Parkinson’s Disease with Mild Cognitive Impairment

Jia, X., Wang, Z., Yang, T., Li, Y., Gao, S., Guorong Wu, A., Jiang, T., & Liang, P. (2018) · Aging and Disease · doi:10.14336/ad.2018.1116 · Cited by 50

Molecular Imaging Approaches in Dementia

Villemagne, V. L., Barkhof, F., Garibotto, V., Landau, S. M., Nordberg, A. K., & van Berckel, B. N. M. (2021) · Radiology · doi:10.1148/radiol.2020200028 · Cited by 56

Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson's disease related dementia.

Bosboom, J. L., Stoffers, D., Stam, C. J., Berendse, H., & Wolters, E. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2009.03.004 · Cited by 51

Frequency of dementia in Parkinson's disease: A systematic review and meta-analysis.

Sousa, C., Alarcão, J., Martins, I. P., & Ferreira, J. (2021) · Journal of Neurological Sciences · doi:10.1016/j.jns.2021.120077 · Cited by 43

Mild cognitive impairment in patients with Parkinson’s disease: An updated mini-review and future outlook

Yu, R., & Wu, R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.943438 · Cited by 49

Free and Cued Recall Memory in Parkinson’s Disease Associated with Amnestic Mild Cognitive Impairment

da Costa, A. L. C., Monaco, M., Zabberoni, S., Peppe, A., Perri, R., Fadda, L., Iannarelli, F., Caltagirone, C., & Carlesimo, G. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086233 · Cited by 49

Cognitive impairment in Parkinson's disease without dementia

Rodríguez‐Ferreiro, J., Cuetos, F., Herrera, E., Menéndez‐González, M., & Ribacoba, R. (2010) · Movement Disorders · doi:10.1002/mds.23239 · Cited by 49

Neuropsychiatry of Parkinson's disease

Kümmer, A., & Teixeira, A. L. (2009) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2009000500033 · Cited by 49

Orthostatic hypotension in Parkinson disease: Impact on health care utilization

Merola, A., Sawyer, R. P., Artusi, C. A., Suri, R., Berndt, Z., Lopez‐Castellanos, J. R., Vaughan, J. E., Vizcarra, J. A., Romagnolo, A., & Espay, A. J. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.11.344 · Cited by 49

Mild cognitive impairment disrupts attention network connectivity in Parkinson's disease: A combined multimodal MRI and meta-analytical study

Bezdíček, O., Ballarini, T., Růžička, F., Roth, J., Mueller, K., Jech, R., & Schroeter, M. L. (2018) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2018.03.011 · Cited by 49

Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson’s Disease: The PPMI Dataset

Fiorenzato, E., Biundo, R., Cecchin, D., Frigo, A. C., Kim, J., Weis, L., Strafella, A. P., & Antonini, A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180390 · Cited by 48

Clinical Features and Correlates of Excessive Daytime Sleepiness in Parkinson's Disease

Xiang, Y., Xu, Q., Sun, Q., Wang, Z., Tian, Y., Fang, L., Yang, Y., Tan, J., Yan, X., Tang, B., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00121 · Cited by 52

Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson’s disease

Badrkhahan, S. Z., Sikaroodi, H., Sharifi, F., Kouti, L., & Noroozıan, M. (2019) · Applied Neuropsychology Adult · doi:10.1080/23279095.2019.1565762 · Cited by 49

β-Glucocerebrosidase activity in GBA -linked Parkinson disease

Huh, Y. E., Chiang, M. S. R., Locascio, J. J., Liao, Z., Liu, G., Choudhury, K., Kuras, Y. I., Tuncali, I., Videnović, A., Hunt, A. L., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009989 · Cited by 49

Benzodiazepines and antidepressants: Effects on cognitive and functional decline in Alzheimer's disease and Lewy body dementia

Borda, M. G., Jaramillo-Jiménez, A., Oesterhus, R., Escudero, J. M. S., Tovar, D., Soennesyn, H., Cano, C. A., Vik‐Mo, A. O., & Aarsland, D. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5494 · Cited by 48

Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer’s disease

Coughlin, D. G., Ittyerah, R., Peterson, C. S., Phillips, J. S., Miller, S., Rascovsky, K., Weintraub, D. A., Siderowf, A. D., Duda, J. E., Hurtig, H. I., et al. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12659 · Cited by 45

Association of Malnutrition with Functional and Cognitive Trajectories in People Living with Dementia: A Five-Year Follow-Up Study

Borda, M. G., Copete, A. M. A., Tovar, D., Jaramillo-Jiménez, A., Giil, L. M., Soennesyn, H., Arteaga, R. C. G., Venegas‐Sanabria, L. C., Kristiansen, I., Chavarro‐Carvajal, D. A., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200961 · Cited by 51

Neuropsychological Assessment for Early Detection and Diagnosis of Dementia: Current Knowledge and New Insights

Alzola, P., Pardo, C. C., Bermejo‐Pareja, F., Sánchez‐Benavides, G., Peña‐Casanova, J., Puertas‐Martín, V., Fernández‐Calvo, B., & Contador, I. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123442 · Cited by 59

Lewy Body and Parkinsonian Dementia

Mollenhauer, B., Förstl, H., Deuschl, G., Storch, A., Oertel, W. H., & Trenkwalder, C. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0684 · Cited by 48

Neuropsychiatric and cognitive symptoms and body side of onset of parkinsonism in unmedicated Parkinson's disease patients

Pellicano, C., Assogna, F., Cravello, L., Langella, R., Caltagirone, C., Spalletta, G., & Pontieri, F. E. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.07.002 · Cited by 48

The differential diagnoses of parkinsonism: Findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics

Munhoz, R. P., Werneck, L. C., & Teive, H. A. G. (2010) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2010.03.003 · Cited by 48

Oxidative Imbalance in Different Neurodegenerative Diseases with Memory Impairment

Gironi, M., Bianchi, A., Russo, A., Alberoni, M., Ceresa, L., Angelini, A., Cursano, C., Mariani, E., Nemni, R., Kullmann, C., et al. (2010) · Neurodegenerative Diseases · doi:10.1159/000319452 · Cited by 48

Psychopathological features in patients with Parkinson's disease and related caregivers' burden

Stella, F., Banzato, C. E. M., Quagliato, E. M. A. B., Viana, M. A., & Christofoletti, G. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2240 · Cited by 48

A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson’s disease in China

Nie, K., Zhang, Y., Wang, L., Zhao, J., Huang, Z., Gan, R., Li, S., & Wang, L. (2012) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.11.039 · Cited by 48

Color Trails Test: Normative Data and Criterion Validity for the Greek Adult Population

Messinis, L., Malegiannaki, A.-C., Christodoulou, T., Panagiotopoulos, V. E., & Papathanasopoulos, P. (2011) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acr027 · Cited by 48

Cholinergic and perfusion brain networks in Parkinson disease dementia

Colloby, S. J., McKeith, I. G., Burn, D. J., Wyper, D. J., O'Brien, J. T., & Taylor, J. (2016) · Neurology · doi:10.1212/wnl.0000000000002839 · Cited by 49

Cortical Thinning and Cognitive Impairment in Parkinson's Disease without Dementia

Zhang, L., Wang, M., Sterling, N. W., Lee, E., Eslinger, P. J., Wagner, D., Du, G., Lewis, M. M., Truong, Y. K.-N., Bowman, F. D., et al. (2015) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2015.2465951 · Cited by 46

Neuropathology of Nonmotor Symptoms of Parkinson's Disease

Jellinger, K. A. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.005 · Cited by 50

Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage

Zou, J., Chen, Z., Liang, C., Fu, Y., Wei, X., Lu, J., Pan, M., Guo, Y., Liao, X., Xie, H., et al. (2018) · Aging and Disease · doi:10.14336/ad.2017.0416 · Cited by 48

Apathy as a behavioural marker of cognitive impairment in Parkinson’s disease: a longitudinal analysis

Martin, G., Mcdonald, K., Allsop, D., Diggle, P., & Leroi, I. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09538-z · Cited by 44

Identifying Parkinson’s disease with mild cognitive impairment by using combined MR imaging and electroencephalogram

Zhang, J., Gao, Y., He, X.-T., Feng, S., Hu, J., Zhang, Q., Zhao, J., Huang, Z., Wang, L., Ma, G., et al. (2021) · European Radiology · doi:10.1007/s00330-020-07575-1 · Cited by 47

Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease

Barba, L., Abu‐Rumeileh, S., Barthel, H., Massa, F., Foschi, M., Bellomo, G., Gaetani, L., Thal, D. R., Parnetti, L., & Otto, M. (2024) · Brain · doi:10.1093/brain/awae203 · Cited by 52

Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease

Vu, T. C., Nutt, J. G., & Holford, N. H. G. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04208.x · Cited by 47

Effect of Rivastigmine on Behavioral and Psychiatric Symptoms of Parkinson’s Disease Dementia

Oh, Y., Kim, J., & Lee, P. H. (2015) · Journal of Movement Disorders · doi:10.14802/jmd.15041 · Cited by 47

BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease

Białecka, M. A., Kurzawski, M., Roszmann, A., Robowski, P., Sitek, E. J., Honczarenko, K., Mak, M., Deptuła-Jarosz, M., Gołąb-Janowska, M., Droździk, M., et al. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2013.12.051 · Cited by 52

The role of the inferior frontal gyri in cognitive processing of patients with Parkinson's disease: A pilot rTMS study

Srovnalová, H., Mareček, R., & Rektorová, I. (2011) · Movement Disorders · doi:10.1002/mds.23663 · Cited by 46

Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study

Pellecchia, M. T., Picillo, M., Santangelo, G., Longo, K., Moccia, M., Erro, R., Amboni, M., Vitale, C., Vicidomini, C., Salvatore, M., et al. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12365 · Cited by 47

Neuropsychiatric Symptoms in Parkinson’s Disease Dementia Are Associated with Increased Caregiver Burden

Oh, Y., Lee, J. E., Lee, P. H., & Kim, J. (2015) · Journal of Movement Disorders · doi:10.14802/jmd.14019 · Cited by 47

The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson’s disease in Italy

Picillo, M., Pellecchia, M. T., Erro, R., Amboni, M., Vitale, C., Iavarone, A., Moccia, M., Allocca, R., Orefice, G., & Barone, P. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1522-6 · Cited by 47

Antisaccade errors reveal cognitive control deficits in Parkinson’s disease with freezing of gait

Walton, C. C., O’Callaghan, C., Hall, J. M., Gilat, M., Mowszowski, L., Naismith, S. L., Burrell, J. R., Shine, J. M., & Lewis, S. J. G. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7910-5 · Cited by 50

Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson's disease

Oh, Y., Kim, J., Hwang, E.-J., & Lyoo, C. H. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.06.022 · Cited by 47

Identifying the neural correlates of doorway freezing in Parkinson's disease

Matar, E., Shine, J. M., Gilat, M., Martens, K. A. E., Ward, P. B., Frank, M. J., Moustafa, A. A., Naismith, S. L., & Lewis, S. J. G. (2019) · Human Brain Mapping · doi:10.1002/hbm.24506 · Cited by 47

Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson’s disease

Low, A., Foo, H., Yong, T. T., Tan, L. C. S., & Kandiah, N. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-319592 · Cited by 48

The interactions of dopamine and oxidative damage in the striatum of patients with neurodegenerative diseases

Li, H., Yang, P., Knight, W. C., Guo, Y., Perlmutter, J. S., Benzinger, T. L. S., Morris, J. C., & Xu, J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14898 · Cited by 47

Morphological basis of Parkinson disease-associated cognitive impairment: an update

Jellinger, K. A. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02522-4 · Cited by 48

Dopaminergic system and dream recall: an MRI study in Parkinson's disease patients

De Gennaro, L., Lanteri, O., Piras, F., Scarpelli, S., Assogna, F., Ferrara, M., Caltagirone, C., & Spalletta, G. (2016) · Human Brain Mapping · doi:10.1002/hbm.23095 · Cited by 45

CSF levels of SNAP-25 are increased early in Creutzfeldt-Jakob and Alzheimer’s disease

Halbgebauer, S., Steinacker, P., Hengge, S., Oeckl, P., Abu‐Rumeileh, S., Anderl‐Straub, S., Lombardi, J., Arnim, C. A. F. V., Giese, A., Ludolph, A. C., et al. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-328646 · Cited by 48

Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease

Periñán, M. T., Macías‐García, D., Jesús, S., Martin‐Rodríguez, J. F., Muñoz‐Delgado, L., Jiménez‐Jaraba, M. V., Buiza‐Rueda, D., Bonilla‐Toribio, M., Adarmes-Gómez, A. D., Gómez‐Garre, P., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11361-y · Cited by 46

Post-mortem neuropathology of idiopathic rapid eye movement sleep behaviour disorder: a case series

Mayà, G., Iranzo, Á., Gaig, C., Sánchez‐Valle, R., Serradell, M., Molina‐Porcel, L., Santamaría, J., Gelpí, E., & Aldecoa, I. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00402-2 · Cited by 50

Effects of transcranial direct current stimulation upon attention and visuoperceptual function in Lewy body dementia: a preliminary study

Elder, G. J., Firbank, M., Kumar, H., Chatterjee, P., Chakraborty, T., Dutt, A., & Taylor, J. (2015) · International Psychogeriatrics · doi:10.1017/s1041610215001180 · Cited by 46

Investigating rapid eye movement sleep without atonia in Parkinson's disease using the rapid eye movement sleep behavior disorder screening questionnaire

Bolitho, S., Naismith, S. L., Terpening, Z., Grunstein, R. R., Melehan, K. L., Yee, B. J., Coeytaux, A., Gilat, M., & Lewis, S. J. G. (2014) · Movement Disorders · doi:10.1002/mds.25832 · Cited by 46

Imaging the Role of Amyloid in PD Dementia and Dementia with Lewy Bodies

Gomperts, S. N. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0472-6 · Cited by 47

Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene

Somme, J. H., Salazar, A. M., González, A., Tijero, B., Berganzo, K., Lezcano, E., Martínez, M. F., Zarranz, J. J., & Gómez‐Esteban, J. C. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.02.019 · Cited by 46

Addenbrooke's Cognitive Examination‐Revised for mild cognitive impairment in Parkinson's disease

McColgan, P., Evans, J., Breen, D. P., Mason, S., Barker, R. A., & Williams‐Gray, C. H. (2012) · Movement Disorders · doi:10.1002/mds.25084 · Cited by 46

Parkinson's disease dementia can be easily detected in routine clinical practice

Dujardin, K., Dubois, B., Tison, F., Durif, F., Bourdeix, I., Péré, J.-J., Duhamel, A., & for the EXECUTIVE study group (2010) · Movement Disorders · doi:10.1002/mds.23391 · Cited by 46

Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson’s Disease

Tang, Y., Ge, J., Liu, F., Wu, P., Guo, S., Liu, Z., Wang, Y., Wang, Y., Ding, Z., Wu, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152716 · Cited by 46

Advanced therapies in Parkinson’s disease: Long-term retrospective study

Merola, A., Espay, A. J., Romagnolo, A., Bernardini, A., Rizzi, L., Rosso, M., Espay, K. J., Zibetti, M., Lanotte, M., & Lopiano, L. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.05.015 · Cited by 46

Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population

Gleerup, H. S., Jensen, C. S., Høgh, P., Hasselbalch, S. G., & Simonsen, A. H. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103361 · Cited by 46

Parkinson's Disease Dementia and Potential Therapeutic Strategies

Caviness, J. N., Lue, L., Adler, C. H., & Walker, D. G. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00216.x · Cited by 46

Alpha-Synuclein and Cognitive Decline in Parkinson Disease

Fan, T.-S., Liu, S. C.-H., & Wu, R. (2021) · Life · doi:10.3390/life11111239 · Cited by 47

Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson’s disease

Ray, N. J., Lawson, R. A., Martin, S. L., Sigurdsson, H. P., Wilson, J., Galna, B., Lord, S., Alcock, L., Duncan, G. W., Khoo, T. K., et al. (2022) · Brain · doi:10.1093/brain/awac127 · Cited by 45

Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s disease

Harvey, J., Reijnders, R. A., Cavill, R., Duits, A., Köhler, S., Eijssen, L., Rutten, B. P. F., Shireby, G. L., Torkamani, A., Creese, B., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00409-5 · Cited by 50

Dementia in Parkinson's Disease

Burn, D. J. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00012-x · Cited by 17

Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis

Goetz, C. G., Emre, M., & Dubois, B. (2009) · Annals of Neurology · doi:10.1002/ana.21455 · Cited by 232

Diagnosis and Treatment of Parkinson's Disease Dementia : An Update

Park, M. Y. (2007) · Journal of Yeungnam Medical Science · doi:10.12701/yujm.2007.24.2s.s159

Clinical phenotype of Parkinson disease dementia

Galvin, J. E., Pollack, J., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000242630.52203.8f · Cited by 264

Dementia associated with Parkinson’s disease: Applying the Movement Disorder Society Task Force criteria

Martínez‐Martín, P., Falup‐Pecurariu, C., Rodríguez‐Blázquez, C., Serrano‐Dueñas, M., Artal, F. J. C., Rojo-Abuín, J. M., & Aarsland, D. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.05.017 · Cited by 64